BrainFx Ai Inc is improving clinical care and accelerating neuroscience. neuroscience. Learn how.

About BrainFx

BrainFx Ai Inc, now part of PlanetCorp, develops advanced neurorehabilitation and cognitive health tools to better understand how the brain functions in everyday life. Designed for use across the lifespan, our digital assessments support clinicians in identifying subtle brain dysfunctions that traditional tests may miss. Rooted in real-world healthcare environments, BrainFx is trusted by organizations working with both children and adults to deliver more personalized, evidence-informed care.

Our story

BrainFx is transforming the way the world understands brain health. Built on nearly two decades of clinical leadership in neurorehabilitation, BrainFx was created to fill a critical gap in cognitive assessment—capturing the real-world impact of mild to moderate brain dysfunction that traditional tools often miss.

Now part of PlanetCorp and operated by BrainFx AI Inc., we combine clinical expertise with advanced AI technology to deliver digital assessments that reflect everyday brain function. Our tools empower healthcare professionals to detect subtle changes early, monitor cognitive performance over time, and personalize care with greater precision.

At BrainFx, we believe brain health is just as essential to track as physical health—and we’re working to make that a reality in healthcare systems around the world.

The Challenge

Traditional standardized assessments often fail to align with real-world observations—particularly in individuals with mild to moderate cognitive dysfunction. These tools tend to overlook complex functional cognitive skills and assess cognition in isolation, without accounting for the impact of physical and psychosocial factors. As a result, clinicians must rely on a mix of disconnected tools, yet still face gaps in accurately understanding how brain dysfunction affects daily life. BrainFx was created to close that gap.

Why BrainFx

There was a clear need for a comprehensive assessment tool that could detect subtle brain dysfunction and reflect the challenges people face in everyday life. Existing tools often missed early signs of conditions like dementia or the milder effects of concussion. BrainFx was created to fill this gap—combining advanced technology, clinical expertise, and research to deliver neurofunctional assessments that provide deeper insights for healthcare teams. Our mission is to improve health outcomes globally by making invisible brain challenges visible.

Our Origins

BrainFx was developed to address a critical gap in brain health assessment—where traditional tools failed to detect early, subtle, and functionally relevant signs of brain dysfunction. The platform was originally created by experienced Occupational Therapists who brought deep clinical insight into the development of a more real-world, neurofunctional approach to cognitive assessment.

Their innovation led to the granting of U.S. Patent No. 10,249,417, covering the core methodology behind BrainFx's unique assessment framework. This intellectual property, along with the BrainFx platform, is now fully owned by PlanetCorp and operated under BrainFx AI Inc.

Today, BrainFx continues its mission with renewed scale and technological backing—empowering healthcare systems to detect, monitor, and support brain health across the lifespan.

Our Mission & Vision

United by a single passion - to make the invisible effects of brain disorders visible - we are a collaborative, dedicated and multi- disciplinary team committed to improving the lives of people everywhere by shedding a light on brain health and paths to rehabilitation.

Our Mission

United by a single passion - to make the invisible effects of brain disorders visible - we are a collaborative, dedicated and multi- disciplinary team committed to improving the lives of people everywhere by shedding a light on brain health and paths to rehabilitation.

Our Vision

United by a single passion - to make the invisible effects of brain disorders visible - we are a collaborative, dedicated and multi- disciplinary team committed to improving the lives of people everywhere by shedding a light on brain health and paths to rehabilitation.

Values

From our mission to the way we work with our clinical network, our values guide everything we do.
Inform

Deliver gold standard assessments for neurofunction so that brain health can be easily integrated into any practice.

Illuminate

Illuminate the path to brain health treatment by delivering clinically useful & unique insights through intelligent analysis and comparative norms.

Empower

Empower people to live life to their full potential through clinical research & innovation that benefits from our Living Brain BankTM, a database of de-identified results from previous assessments.

Care

Enable healthcare institutions to deliver the best care possible for their patients to improve quality of life across the youth, elderly, and those suffering from brain dysfunction resulting from concussions, Alzheimer's Disease and Dementia etc.

Our Founders
Siva Vakalapudi
Chairman, BrainFx Ai Inc
Founder & CEO, PlanetCorp

Siva Vakalapudi is a visionary entrepreneur and the founder of PlanetCorp, an innovation-driven holding company focused on applying AI to solve some of the world’s most complex challenges. With a strong belief in the transformative power of intelligent systems, Siva led the strategic acquisition of BrainFx to accelerate the future of brain health through technology. While not from a clinical background, he brings executional leadership, operational guidance, and global perspective to the BrainFx mission. As Chairman, Siva is supporting the transition to a new CEO while guiding BrainFx into its next phase of AI-driven impact.

Linkedin
Chris Jugovic
Business Head, BrainFx Ai Inc
General Manager, PlanetCorp

Since 2018, Chris has played a key leadership role at BrainFx, driving the development of innovative tools that reflect the complexities of everyday life and cognition. As Business Head, he is dedicated to empowering clinicians with advanced assessments that uncover subtle cognitive dysfunctions, support meaningful functional outcomes, and make brain health more responsive to real-world needs.

Linkedin
Tracy Milner
Co-founder & Advisor

Inspired by her own frustration on the front lines, Tracy is passionate about unlocking how the brain functions to improve everyday life. By colliding clinical care with AI and technology, she envisions a world where monitoring your brain health is as common as your annual physical. Where clinicians don’t need to tell another patient with early or milder cognitive dysfunction to ‘come back when it is worse’ because they are empowered to act instead. When not striving to make a global impact on healthcare, ask to see photos of Tracy’s twice-a-year birthday cakes or pumpkin carvings.

Linkedin
Heather Condello
Co-founder & Advisor

Fascinated within her clinical practice to always learn more about the functional presentation of brain disorders and passionate to educate anyone who will listen on the significant impact mild brain disorders can have in one’s daily life, Heather is driven to promote BrainFx’s mission to the world. Heather envisions a healthcare system where monitoring brain health and understanding functional implications of brain impairment are as commonplace as tracking physical health. When not working, Heather enjoys travelling to warm destinations, keeping active, and has a newfound determination to work through her bucket list.

Linkedin

Partners

Advancing cognitive care together.

Metriks Education Inc., founded in 2004, specializes in the measurement of physical function. Metriks designs and manufactures innovative tools to measure human performance, complemented by their continuing education assessment certification courses. The Metriks Rehabilitation Assessment Management (RAM) software platform automates assessment data collection and report writing.

Insightin Health’s AI-driven platform inGAGE™ leverages SDoH and clinical data to identify the best possible ways to communicate with members on a one-to-one level. In partnership with BrainFx, inGAGE™ can now generate a richer and Comprehensive member health risk assessment by also giving consideration to a member’s cognitive well-being. The Insightin Health and BrainFx partnership makes for an integrated and cyclical preventative health care flow.

The Canadian Association of Occupational Therapists (CAOT) is the national organization that supports the more than 18,000 occupational therapists (OTs) who work or study in Canada. OTs improve the health and well-being of Canadians by creating client-centred solutions that help them participate more fully in activities that are important to their everyday lives. CAOT provides products, services and learning opportunities that assist OTs in achieving excellence in their professional practice. Additionally, CAOT provides leadership in the development and promotion of the occupational therapy profession in Canada and internationally.

The Ontario Society of Occupational Therapists (OSOT) is the voluntary provincial professional association of Ontario’s occupational therapists. With focus in the areas of Member Services, Government Relations, Professional Promotion, Professional Development and Practice Support, the Society serves and represents the interests of members and promotes the profession of occupational therapy in the province of Ontario.
OSOT is currently a membership of over 4,500 occupational therapists, students of occupational therapy and others who seek to associate with the profession. From its early roots in 1921, as the first occupational therapy organization in Canada, OSOT has provided professional leadership to the growing profession throughout its history in Canada.

Helius Medical Technologies is a neurotech company focused on neurological wellness.  The Company’s purpose is to develop, license and acquire unique and non-invasive platform technologies that amplify the brain’s ability to heal itself.  The Company’s first commercial product is the Portable Neuromodulation Stimulator (PoNS™).
For more information, visit www.ponstreatment.ca or www.heliusmedical.com

NeuroCatch is a subsidiary of HealthTech Connex. 
The NeuroCatch® device is an objective, rapid neuro-physiological brain function assessment system licensed by Health Canada.
For more information, visit www.neurocatch.com or healthtechconnex.com

Maple is a virtual care platform that allows Canadians to see a doctor online within minutes — 24 hours a day, seven days a week. Patients can securely text, audio, or video chat with a Canadian-licensed doctor for diagnosis, treatment, and prescriptions. We also offer a wide variety of specialties such as dermatology, endocrinology, and mental health therapy, which can be booked in under 72 hours. Incorporated in 2015, Maple has been operating in Canada since late 2016. We initially launched in Ontario and now offer services in every province and territory of Canada.
For more information, visit www.getmaple.ca

Think Research is a rapidly-growing healthcare software company based in downtown Toronto. Their mission is to organise the world’s health knowledge so that everyone gets the best care. Their point-of-care, clinical decision support tools are used by health systems and healthcare providers (i.e. doctors, nurses, pharmacists, and more) to dramatically improve healthcare outcomes, save clinicians’​ time, and reduce administrative burdens and costs.  Today, with a growing network of clients, collaborators and partners, this principle of collaboration is supported by our entire suite of applications. Deployed in over 2,200 health care facilities across Canada, the US and around the world, their tools are transforming healthcare, one clinical support tool at a time.
For more information, visit www.thinkresearch.com

Our latest research

Working with the Mayo Clinic to understand Long-COVID

This study focuses on understanding the neurological impact of Long-COVID by developing a solution that assists clinicians and researchers to better understand and address the impacts of this new and emerging phenomenon.